Item 7.01. Regulation FD Disclosure.

Soleno Therapeutics, Inc., a Delaware corporation (the "Company"), is furnishing presentation materials included as Exhibit 99.1 to this report pursuant to Item 7.01 of Form 8-K. The Company is not undertaking to update this presentation. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including Exhibit 99.1).

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits.

 Exhibit
   No.           Description

   99.1            Presentation Materials

   104           Cover Page Interactive Data File (formatted as inline XBRL and
                 contained in Exhibit 101).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses